(Q44945087)

7 December 2017

title

Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

20 November 2022

author name string

T. Kawamura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1773825

20 November 2022

H. Adachi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1773825

20 November 2022

T. Ogawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1773825

20 November 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

7 December 2017

22 October 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1773825

full work available at URL

20 November 2022

https://api.elsevier.com/content/article/PII:001429999190897Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

https://api.elsevier.com/content/article/PII:001429999190897Y?httpAccept=text/plain

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

European Journal of Pharmacology

20 November 2022

published in

1 reference

7 December 2017

volume

203

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

399-404

1 reference

7 December 2017

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

New Tables for Multiple Comparisons with a Control

20 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Prostaglandins and the control of blood flow in the canine myocardium

20 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart

20 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".

20 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action

20 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration

20 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Moving together: K+ channel openers and ATP-sensitive K+ channels

20 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Heart rate reduction, a new and old therapeutic principle?

20 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Pharmacological influence of specific bradycardic agents on the pacemaker current of sheep cardiac Purkinje fibres. A comparison between three different molecules

20 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

Alinidine as a model of the mode of action of specific bradycardic agents on SA node activity

20 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90897-Y

20 November 2022

Identifiers

1 reference

7 December 2017

1 reference